4 Penny Stocks Insiders Are Buying
When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision.
12 Health Care Stocks Moving In Thursday’s After-Market Session
Gainers
MorphoSys (NASDAQ:MOR) stock moved upwards by 15.07% to $16.26 during Thursday's after-market session. The market value of their outstanding shares is at $2.2 billion.
Stocks That Hit 52-Week Lows On Friday
On Friday morning, 155 companies achieved new lows for the year.
The Daily Biotech Pulse: J&J Announces CEO Transition, FibroGen’s Roxadustat Approved In Europe, GeoVax, Sorrento Announce COVID-19 Vaccine Data
Here's a roundup of top developments in the biotech space over the last 24 hours.
Scaling The Peaks
(Biotech Stocks Hitting 52-week Highs Aug. 19)
Stocks That Hit 52-Week Lows On Thursday
Thursday morning, 173 companies reached new 52-week lows.
Cellectar Receives $2M NIH Grant For Rare Lymphoma Study
Cellectar Biosciences Inc (NASDAQ:CLRB) has received a peer-reviewed National Institutes of Health (NIH) Phase II Small Business Innovation Research…
Cellectar Awarded $2.0M Phase II NIH SBIR Grant To Support Pivotal Study Of Iopofosine I-131 In Waldenstrom’s Macroglobulinemia
Cellectar Biosciences, Inc. (NASDAQ:CLRB), a late-stage clinical biopharmaceutical company focused on the discovery and development of drugs for the treatment of cancer, today announced it has been awarded a
Cellectar Announces Manufacturing And Supply Agreement With Evergreen Theragnostics For CLR-131, Now Known As iopofosine I-131; Financial Terms Not Disclosed
Evergreen to provide clinical and commercial supply of iopofosine I-131 (also known as CLR 131)
Agreement adds second manufacturer and expands Cellectar's current supply capabilities
FLORHAM PARK, N.J., Aug.